We are live on ! Find out more
AA

Altrafin AG Portfolio holdings

AUM $255M
1-Year Est. Return 21.67%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+21.67%
3 Year Est. Return
+97.62%
5 Year Est. Return
10 Year Est. Return
AUM
$255M
AUM Growth
-$34.9M
Cap. Flow
-$82.3M
Cap. Flow %
-32.23%
Top 10 Hldgs %
60.31%
Holding
56
New
4
Increased
10
Reduced
24
Closed
12

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$1.22M
2
RBRK icon
Rubrik
RBRK
+$1.18M
3
NTR icon
Nutrien
NTR
+$1.05M
4
SAIL
SailPoint Inc
SAIL
+$933K
5
CVX icon
Chevron
CVX
+$913K

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.8M
2
AMZN icon
Amazon
AMZN
+$8.65M
3
TSM icon
TSMC
TSM
+$6.3M
4
CRWD icon
CrowdStrike
CRWD
+$6.27M
5
FTNT icon
Fortinet
FTNT
+$6.1M

Sector Composition

Rank Sector Weight
1 Technology 36.89%
2 Financials 19.28%
3 Communication Services 14.48%
4 Consumer Discretionary 8.89%
5 Healthcare 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.24T
$29.7M 11.63%
83,081
-35,480
-30% -$12.8M
MSFT icon
2
Microsoft
MSFT
$3.65T
$25.1M 9.84%
67,380
-7,546
-10% -$3.05M
AMZN icon
3
Amazon
AMZN
$2.82T
$19.7M 7.73%
82,803
-34,444
-29% -$8.65M
MA icon
4
Mastercard
MA
$525B
$18.1M 7.08%
35,206
-10,865
-24% -$5.42M
TSM icon
5
TSMC
TSM
$2.16T
$15.3M 6%
32,088
-15,526
-33% -$6.3M
JPM icon
6
JPMorgan Chase
JPM
$948B
$12.9M 5.04%
39,326
+140
+0.4% +$43.5K
ACWI icon
7
iShares MSCI ACWI ETF
ACWI
$33.3B
$9.03M 3.54%
57,500
AAPL icon
8
Apple
AAPL
$4.52T
$8.62M 3.38%
29,806
-10,610
-26% -$3.03M
ICE icon
9
Intercontinental Exchange
ICE
$90.8B
$7.77M 3.04%
63,098
+3,270
+5% +$491K
FTNT icon
10
Fortinet
FTNT
$113B
$7.73M 3.03%
50,320
-52,795
-51% -$6.1M
NVDA icon
11
NVIDIA
NVDA
$5.16T
$7.72M 3.02%
38,599
-8,340
-18% -$1.71M
CRWD icon
12
CrowdStrike
CRWD
$189B
$7.7M 3.02%
40,384
-44,108
-52% -$6.27M
LLY icon
13
Eli Lilly
LLY
$1.1T
$7.65M 2.99%
6,374
+20
+0.3% +$20.4K
NVO
14
Novo Nordisk
NVO
$215B
$6.71M 2.63%
139,963
-34,450
-20% -$1.48M
SPGI icon
15
S&P Global
SPGI
$128B
$5.15M 2.02%
12,637
-9,140
-42% -$3.86M
UNH icon
16
UnitedHealth
UNH
$356B
$4.96M 1.94%
11,931
-4,758
-29% -$1.76M
MCO icon
17
Moody's
MCO
$88.9B
$4.35M 1.7%
9,605
-3,070
-24% -$1.38M
PANW icon
18
Palo Alto Networks
PANW
$277B
$3.91M 1.53%
11,453
-12,953
-53% -$2.96M
META icon
19
Meta Platforms (Facebook)
META
$1.45T
$3.88M 1.52%
6,887
-5,173
-43% -$3.16M
GE icon
20
GE Aerospace
GE
$363B
$3.86M 1.51%
10,324
-1,933
-16% -$605K
AMD icon
21
Advanced Micro Devices
AMD
$782B
$3.78M 1.48%
6,510
-6,830
-51% -$2.8M
NFLX icon
22
Netflix
NFLX
$342B
$3.39M 1.33%
47,504
-32,304
-40% -$2.84M
UBER icon
23
Uber
UBER
$164B
$3.18M 1.25%
44,083
-16,280
-27% -$1.19M
OKTA icon
24
Okta
OKTA
$22.7B
$3M 1.17%
21,970
+12,970
+144% +$1.22M
MELI icon
25
Mercado Libre
MELI
$101B
$2.69M 1.06%
1,587
-557
-26% -$951K

Similar funds

Altrafin AG's Q2 2026 Portfolio in Review

As of Q2 2026, Altrafin AG held 56 positions worth $255M, down 12% from $290M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Altrafin AG withdrew a net $82.3M in Q2 2026, closing 12 positions and reducing 24 holdings. Its most notable exit was Equifax, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Altrafin AG opened a new position in Nutrien worth $944K.

  • Altrafin AG's largest Q2 2026 buy was Nutrien: 15,000 shares worth $944K.
  • Altrafin AG added most to Okta in Q2 2026, an estimated $1.22M increase.
  • Altrafin AG's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $12.8M.
  • Altrafin AG fully exited Equifax in Q2 2026, selling an estimated $2.12M.
  • Altrafin AG's ten largest holdings make up 60% of its $255M portfolio in Q2 2026.
  • Altrafin AG opened 4 new positions and closed 12 in Q2 2026.
  • Altrafin AG's portfolio value fell 12% quarter-over-quarter to $255M.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.